Johnson & Johnson Vision Care manufacturing facility in Limerick
Johnson & Johnson Limerick

Johnson & Johnson Vision Care Ireland UC has returned to profitability with pre-tax earnings of €501.69 million, newly filed accounts show. The Limerick-based eye care unit of the US healthcare multinational employs 1,632 people at its National Technology Park facility.

The company recorded a pre-tax loss of €792.9 million in 2024 after taking an exceptional €1.06 billion expense arising from a new pricing agreement with Irish and US tax authorities.

Key facts

  • Revenue rose 15 per cent from €1.2 billion to €1.38 billion
  • Post-tax profit stood at €427.56 million after a corporation tax charge of €74.12 million
  • Workforce fell slightly from 1,658 to 1,632, with 1,556 in manufacturing and 76 in administration
  • The company paid a dividend of €1.1 billion to parent firm Janssen Pharmaceutical UC
  • Shareholder funds totalled €1.89 billion at the end of December 2025

Revenue growth driven by global demand

Directors said the revenue increase was predominantly driven by increased demand in the global market. The company benefited from €2 billion in income from investment in subsidiaries during 2025, which was largely offset by a €1.9 billion impairment of investments in a subsidiary.

The connected income and impairment arose from a company subsidiary, Vision Care Finance UC, being placed into liquidation on 30 September 2025. Prior to the liquidation, the company recognised investment income of €2 billion in respect of distributions received from the subsidiary.

Employment and cost structure

Staff costs decreased from €169.39 million to €161.24 million, which included wages and salaries of €131.28 million and share-based payments of €2.14 million. Pay to directors more than doubled from €1.02 million to €2.5 million, made up of emoluments of €2.5 million and €55,000 in gains on share options exercised.

The profit takes account of non-cash depreciation charges of €98.35 million and research and development costs of €10.9 million, offset by R&D tax credits of €3.2 million. Profits were reduced by a €10.67 million non-cash impairment of fixed assets.

Across Ireland, Johnson & Johnson employs more than 6,000 people in 10 sites in five counties: Cork, Dublin, Limerick, Galway and Mayo. Directors said they expect that the present level of activity will remain for the foreseeable future and that despite ongoing competitive challenges in the marketplace, they are satisfied the company will continue trading profitably.

Reporting based on original coverage by RTÉ News.

LEAVE A REPLY

Please enter your comment!
Please enter your name here